PPLPHARMA.NSPPLPHARMA.NSNSE
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-6.6%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
-6.6%/yr
Quarterly compound
Percentile
P50
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
2 qtr
Consecutive growthRecovering
PeriodValue
Q4 20252.67%
Q3 2025-57.49%
Q2 2025-62.61%
Q1 2025137.06%
Q4 2024101.63%
Q3 202435.32%
Q2 2024-39.54%
Q1 2024-33.95%
Q4 20230.77%
Q3 202313.50%
Q2 202368.51%
Q1 2023-38.94%
Q4 20223.28%
Q3 202216.35%
Q2 202225.50%
Q1 2022-27.07%
Q4 20212.08%
Q3 20214.36%
Q2 20210.00%